Eltrombopag – July 2026

  • Brand names:
    • Revolade®
  • Pharmaceutical Company:
    • NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED
  • Condition/Indication: Severe aplastic anaemia Severe thrombocytopenia
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026